FY17 bulk funding for: drug: ventavis 20MCG/m>ampule (iloprost 10MCG/ML, inhl, oral, 1ML)
Ended Awarded Last action
- Contract number
- VA26017J1578
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $56,824
Award facts
- Contract value 100% obligated
- $56,823.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$80,745 | |
| Original award | $137,569 |
Quick answers
Who was awarded contract VA26017J1578?
VA26017J1578 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2016.
How much is contract VA26017J1578 worth?
The government has obligated $56,824 on VA26017J1578.
Is contract VA26017J1578 an order under another contract?
Yes. VA26017J1578 is a BPA call under V797P5160B-VA797P16A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26017J1578 competed?
The extent of competition for VA26017J1578 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award